Meeting Banner
Abstract #1544

Dose reduction in myxoid liposarcomas: Initial descriptive results in the evaluation of response using multiparametric MRI.

Evanthia Kousi1, Maria A Schmidt1, Shane Zaidi2, Khin Thway 3, Cyril Fisher 3, Myles Smith4, Dirk Strauss4, Andrew Hayes4, Eleanor Moskovic5, Nicos Fotiadis5, Elizabeth Barquin2, Komal Amin6, Rick Haas7, Christina Messiou5, and Aisha Miah2

1CR-UK and EPSRC Cancer Imaging Centre, Royal Marsden NHS Foundation Trust & Institute of Cancer Research, Sutton, United Kingdom, 2Sarcoma Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom, 3Pathology, Royal Marsden NHS Foundation Trust, London, United Kingdom, 4Academic Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom, 5Radiology, Royal Marsden NHS Foundation Trust, London, United Kingdom, 6Radiotherapy, Royal Marsden NHS Foundation Trust, London, United Kingdom, 7Radiotherapy, Neetherlands Cancer Institute, Amsterdam, Netherlands

Compared to other soft tissue sarcomas (STSs), myxoid liposarcomas (MLSs) are exquisitely radiosensitive. The clinicopathological response following pre-operative radiotherapy at 50 Gy/25# in MLS might be due to radiation induction vascular damage. Here we report initial results in using multiparametric MRI (diffusion-weighted imaging, pharmacokinetic modelling and T2* measurements) to evaluate MLS response during and after preoperative RT. Dynamic contrast-enhanced examinations demonstrated both heterogeneous and homogeneous enhancement patterns. The tissue enhancement curve was monotonically-increasing in all cases, suggesting a distinct vascular pattern. Permeability and perfusion decreases from baseline in responders show Ktrans and IAUGC60 can potentially predict response.

This abstract and the presentation materials are available to members only; a login is required.

Join Here